Insider Trading History of Weber Eckard

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Weber Eckard since 2007. The trader's CIK number is 1279800. At the time of the last reporting, Weber Eckard was the Director of Tranzyme Inc. (stock ticker symbol TZYM). Also see all insider trading activities at Tranzyme Inc.

Note that in the past WEBER ECKARD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (NOVC) by Weber Eckard

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 NOVC 0 $0 100,000 $1,164,313 0 $0

Yearly summary of insider trading at Orexigen Therapeutics, Inc. (OREX) by Weber Eckard

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 OREX 160,000 $1,920,000 0 $0 0 $0

Yearly summary of insider trading at Tranzyme Inc (OCRX) by Weber Eckard

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 OCRX 0 $0 0 $0 11,969 $11,011


Insider trading activities at 3 companies by Weber Eckard:

1. Paratek Pharmaceuticals, Inc. (NOVC)

2. Orexigen Therapeutics, Inc. (OREX)

3. Tranzyme Inc (OCRX)

Table 1. Insider trading of Paratek Pharmaceuticals, Inc. (NOVC) by Weber Eckard

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-06-07 NOVC Sale 46,900 10.96 513,930
2007-06-08 NOVC Sale 3,100 10.93 33,883
2007-06-05 NOVC Sale 50,000 12.33 616,500

Table 2. Insider trading of Orexigen Therapeutics, Inc. (OREX) by Weber Eckard

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-04-26 OREX Buy 160,000 12.00 1,920,000

Table 3. Insider trading of Tranzyme Inc (OCRX) by Weber Eckard

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-01-04 OCRX Option Ex 11,969 .92 11,011

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Weber Eckard (Director of Tranzyme Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.